-
European Thrombosis Business, Aspen Pharmacare Holdings Limited
$759M
-
Cold-EEZE
$50M
Cold-EEZE develops and manufactures zinc gluconate products for cold and throat problems.
-
Specialty And Generics Business, Renaissance Acquisition Holdings, LLC
$950M
-
Meda AB
$7.2B
Meda is a developer and marketer of respiratory, dermatology, pain and inflammation therapy products.